Icon Plc (ICLR)

Jan 20, 2025

Icon (ICLR) 3-Year EPS without NRI Growth Rate : 8.70% (As of Sep. 2024) - GuruFocus.com

Jan 20, 2025

Jan 19, 2025

Icon PLC (ICLR) Beats Q1 Earnings and Revenue Estimates - MSN

Jan 19, 2025

Jan 15, 2025

Icon sees FY25 adjusted EPS $13.00-$15.00, consensus $14.93 - Yahoo Finance

Jan 15, 2025

Jan 14, 2025

Icon PLC (ICLR) Stock Price Down 6.6% on Jan 14 - GuruFocus.com

Jan 14, 2025

Jan 14, 2025

Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty - Benzinga

Jan 14, 2025

Jan 14, 2025

ICON plc stock retains Overweight rating amid conservative growth forecasts - Investing.com India

Jan 14, 2025

Jan 14, 2025

ICON plc stock retains Overweight rating amid conservative growth forecasts By Investing.com - Investing.com South Africa

Jan 14, 2025

Jan 14, 2025

Clinical Trials Support Services Market Poised for Notable Expansion by 2030, Driven by Substantial Investments in R&D from Pharmaceutical and Biopharmaceutical Companies - GlobeNewswire Inc.

Jan 14, 2025

Jan 14, 2025

ICON Issues Financial Guidance for Full Year 2025 - sharewise

Jan 14, 2025

Jan 14, 2025

ICON plc Announces 2025 Financial Guidance Amid Market Challenges - TipRanks

Jan 14, 2025

Jan 13, 2025

Decentralized Clinical Trials Market Recent Growth: Market - openPR

Jan 13, 2025

Jan 10, 2025

ICON Public (NASDAQ:ICLR) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World

Jan 10, 2025

Jan 08, 2025

ICON Survey: 97% Use Biomarkers in Neurodegenerative Trials, But Innovation Gaps Persist - StockTitan

Jan 08, 2025

Jan 08, 2025

RBC Capital Initiates Coverage of ICON Public Limited (ICLR) with Outperform Recommendation - MSN

Jan 08, 2025

Jan 07, 2025

ICON's SWOT analysis: CRO giant faces headwinds amid long-term growth potential - Investing.com India

Jan 07, 2025

Jan 07, 2025

ICON plc draws bullish views at RBC on attractive valuation - MSN

Jan 07, 2025

Jan 07, 2025

Icon PLC (ICLR) Stock Price Up 4.66% on Jan 7 - GuruFocus.com

Jan 07, 2025

Jan 07, 2025

ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 07, 2025

Jan 07, 2025

ICON plc to Present at the J.P. Morgan Healthcare Conference - TipRanks

Jan 07, 2025

Jan 06, 2025

Why Icon Plc Shares Face Rocky Times Ahead - TipRanks

Jan 06, 2025

Dec 31, 2024

ICON Properties Plc (ICON.mw) Q42024 Interim Report - AfricanFinancials

Dec 31, 2024

Dec 23, 2024

ICON Clinches TIME Magazine's Top CRO Ranking, Dominates Industry Awards in 2024 - StockTitan

Dec 23, 2024

Dec 20, 2024

ICON appoints Barry Balfe as COO - MSN

Dec 20, 2024

Dec 19, 2024

Bioanalytical Services Market Key Players AnalysisPPD, Inc., - openPR

Dec 19, 2024

Dec 18, 2024

ICON plc appoints Barry Balfe as new COO By Investing.com - Investing.com Australia

Dec 18, 2024

Dec 18, 2024

ICON plc Appoints Barry Balfe as Chief Operating Officer - TipRanks

Dec 18, 2024

Dec 18, 2024

ICON plc appoints Barry Balfe as new COO - Investing.com

Dec 18, 2024

Dec 18, 2024

ICON Appoints 20-Year Veteran Barry Balfe as Chief Operating Officer to Drive Strategic Growth - StockTitan

Dec 18, 2024

Dec 18, 2024

Truist cuts ICON price target to reflect company commentary - Investing.com

Dec 18, 2024

Dec 18, 2024

ICON's SWOT analysis: CRO giant navigates turbulent market - Investing.com

Dec 18, 2024

Dec 16, 2024

October 2025 Options Now Available For Icon - Nasdaq

Dec 16, 2024

Dec 16, 2024

Contract Research Organization Services Market Set to Witness Significant Growth by 2024-2031: IQVIA, LabCorp, - EIN News

Dec 16, 2024

Dec 11, 2024

ICON's SWOT analysis: cro stock navigates challenges amid industry shifts - Investing.com

Dec 11, 2024

Dec 11, 2024

Preclinical Assets Market CAGR of 7.5% Size, Share, Trends, Future Prospect By 2024-2031 | Eurofins - EIN News

Dec 11, 2024

Dec 11, 2024

Biomarker Research Services Market Set to Witness Significant Growth by 2024-2031:Reprocell Corporation, - EIN News

Dec 11, 2024

Dec 10, 2024

At US$219, Is ICON Public Limited Company (NASDAQ:ICLR) Worth Looking At Closely? - Simply Wall St

Dec 10, 2024

Dec 09, 2024

ICON Public Limited Company (ICLR) Fell on Reduced Guidance - Insider Monkey

Dec 09, 2024

Dec 09, 2024

Virtual Clinical Trials Market Key Players AnalysisICON, plc; Parexel International Corporation; IQVIA; Covance. - openPR

Dec 09, 2024

Dec 05, 2024

ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption - sharewise

Dec 05, 2024

Nov 29, 2024

Top 30 IQVIA Alternatives & Competitors in 2025 - Marketing91

Nov 29, 2024

Nov 22, 2024

Icon PLC (ICLR) Down 4.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Nov 22, 2024

Nov 22, 2024

ICON (NASDAQ:ICLR) stock performs better than its underlying earnings growth over last five years - Simply Wall St

Nov 22, 2024

Nov 21, 2024

Should You Retain Your Conviction in Icon Plc (ICLR)? - Yahoo Finance

Nov 21, 2024

Nov 20, 2024

ICON stock labeled a "Fresh Pick" as Baird bets on recovery at current valuation - Investing.com

Nov 20, 2024

Nov 18, 2024

Pharmacovigilance and Drug Safety Software Market Skyrockets to $359.30 Million by 2031 Dominated by Tech GiantsArisEurope, ICON plc and Syneos Health | The Insight Partners - GlobeNewswire

Nov 18, 2024

Nov 17, 2024

Redburn Atlantic Initiates Coverage of ICON Public Limited (ICLR) with Neutral Recommendation - MSN

Nov 17, 2024

Nov 17, 2024

ICON Public Limited (NASDAQ:ICLR) Shares Sold by Entropy Technologies LP - MarketBeat

Nov 17, 2024

Nov 15, 2024

ICON Public Limited Company (ICLR): Among 12 High Growth Large Cap Stocks to Buy Now - Yahoo Finance

Nov 15, 2024